[1]
T. . Vahedpour, M. Nazari, E. Rezaee, and S. A. Tabatabai, “Design, synthesis and biological evaluation of new 2,5-diaryl-1,3,4-oxadiazole derivatives as selective cyclooxygenase-2 inhibitors : Novel 2,5-diaryl-1,3,4-oxadiazole derivatives as selective cyclooxygenase-2 inhibitors”, Int Pharm Acta, vol. 4, no. 1, pp. 4e3:1–6, May 2021.